Sponsor Pipeline

Shenzhen Majory Biotechnology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07208149 A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced… Triple-Negative Breast Cancer (TNBC) Recruiting
NCT07235202 A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or… Pancreatic Ductal Adenocarcinoma (PDAC) Recruiting
Disease Areas
Breast Cancer (1) Triple-Negative Breast Cancer (1) Pancreatic Cancer (1)
Get alerts when Shenzhen Majory Biotechnology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free